We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Stem Cell-Based Cultures Used for Brain Disease Research

By LabMedica International staff writers
Posted on 08 Aug 2018
A team of neurological disease researchers used stem cell technology to culture mini-organoids comprising all the major cell types found in the human cerebral cortex - including oligodendrocytes - for brain structure/function research.

Oligodendrocytes make myelin, the fatty substance that wraps, supports, and insulates nerve cells and connections. More...
Nerve cells that lack myelin cannot communicate effectively and may degenerate.

Cerebral organoids have been shown to be an accessible system for investigations of cellular composition, interactions, and organization of the brain but have lacked oligodendrocytes. To correct this problem, investigators at Case Western Reserve University School of Medicine (Cleveland, OH, USA) reproducibly generated oligodendrocytes and myelin in "oligocortical spheroids" derived from human pluripotent stem cells.

The investigators reported in the July 25, 2018, online edition of the journal Nature Methods that molecular features consistent with those of maturing oligodendrocytes and early myelin appeared by week 20 in culture, with further maturation and myelin compaction evident by week 30.

Drugs that promoted myelin formation were found to enhance the rate and extent of oligodendrocyte generation and myelination, while spheroids generated from human subjects with the genetic myelin disorder Pelizaeus-Merzbacher disease recapitulated human disease phenotypes.

“We have taken the organoid system and added the third major cell type in the central nervous system—oligodendrocytes—and now have a more accurate representation of cellular interactions that occur during human brain development,” said senior author Dr. Paul Tesar, associate professor of genetics and genome sciences at Case Western Reserve University School of Medicine. “This is a powerful platform to understand human development and neurological disease. Using stem cell technology we can generate nearly unlimited quantities of human brain-like tissue in the lab. Our method creates a "mini-cortex", containing neurons, astrocytes, and now oligodendrocytes producing myelin. This is a major step toward unlocking stages of human brain development that previously were inaccessible.”

“Our method enables generation of human brain tissue in the laboratory from any patient,” said Dr. Tesar. “More broadly, it can accurately recapitulate how the human nervous system is built and identify what goes wrong in certain neurological conditions.”

Related Links:
Case Western Reserve University School of Medicine


Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hybrid Pipette
SWITCH
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: AI-powered ctDNA analysis provides clinicians with a new lens to monitor disease evolution (Photo courtesy of Brandon Stelter, Katie Han, Kyle Smith, and Paul Northcott)

AI-Powered Liquid Biopsy Classifies Pediatric Brain Tumors with High Accuracy

Liquid biopsies offer a noninvasive way to study cancer by analyzing circulating tumor DNA in body fluids. However, in pediatric brain tumors, the small amount of ctDNA in cerebrospinal fluid has limited... Read more

Immunology

view channel
Image: The TmS computational biomarker analyzes tumor gene expression and microenvironment data to guide treatment decisions (Photo courtesy of MD Anderson Cancer Center)

New Biomarker Predicts Chemotherapy Response in Triple-Negative Breast Cancer

Triple-negative breast cancer is an aggressive form of breast cancer in which patients often show widely varying responses to chemotherapy. Predicting who will benefit from treatment remains challenging,... Read more

Pathology

view channel
Image: Sophie Paczesny, M.D., Ph.D and her team have made BIOPREVENT freely available for researchers and clinician to test and learn from (Photo courtesy of Cliff Rhodes)

AI Tool Uses Blood Biomarkers to Predict Transplant Complications Before Symptoms Appear

Stem cell and bone marrow transplants can be lifesaving, but serious complications may arise months after patients leave the hospital. One of the most dangerous is chronic graft-versus-host disease, in... Read more

Industry

view channel
Image: QuidelOrtho has entered into a strategic supply agreement with Lifotronic to expand its global immunoassay portfolio (Photo courtesy of QuidelOrtho)

QuidelOrtho Collaborates with Lifotronic to Expand Global Immunoassay Portfolio

QuidelOrtho (San Diego, CA, USA) has entered a long-term strategic supply agreement with Lifotronic Technology (Shenzhen, China) to expand its global immunoassay portfolio and accelerate customer access... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.